Wound Healing / Keloids Flashcards
A 17-year-old boy undergoes excision of a congenital nevus of the scalp. Prior to excision, he underwent placement of a subgaleal tissue expander. Which of the followinggrowth factors is most likely to be upregulated during ischemia in this patient?
A) Epidermal B) Keratinocyte C) Platelet-derived D) Transforming E) Vascular endothelial
E) Vascular endothelial
Vascular endothelial growth factor
Vascular endothelial growth factor (VEGF) is an important mediator of wound healing and is necessary for angiogenesis. It was originally discovered as a protein secreted by tumor cells to increase the permeability of local blood vessels to circulating macromolecules. It has been shown to increase endothelial growth and migration and enhance glucose transport in the endothelial cell, which is needed to match the increased energy required during angiogenesis. Hypoxia has been shown to be a potent stimulus for the expression of VEGF, and current research has been directed at utilizing VEGF to augment healing and viability in situations of tissue ischemia.
A 10-year-old girl is referred to the office because of a large, full-thickness cranial defect after sustaining a traumatic injury. Reconstruction with a split cranial bone graft is performed. Which of the following is the most likely mechanism by which the bone graft heals? A) Dural ossification B) Osteoconduction C) Osteogenesis D) Osteoinduction E) Vasculogenesis
B) Osteoconduction
Method of healing after split cranial bone grafting
The most likely mechanism of split cranial bone graft healing is osteoconduction. The split cranial bone graft is primarily cortical. After it isseparated from its blood supply, it serves as a nonviable scaffold for the ingrowth of blood vessels and osteoprogenitor cells from the recipient site. This process of osteoconduction, or creeping substitution, eventually leads to resorption and replacement of most of the graft with new bone. The graft becomes fully osseointegrated with the recipient site
Osteoconduction
The process of osteoconduction, or creeping substitution, eventually leads to resorption and replacement of most of the graft with new bone, after a graft is infiltrated as a scaffold with vessels and osteoprogenitor cells. The graft becomes fully osseointegrated with the recipient site
Spontaneous dural ossification
Spontaneous dural ossification can heal full-thickness cranial defects in infancy. After 12 to 18 months of age, the dura will not spontaneously ossify
Osteogenesis
Osteogenesis is the primary mechanism of bone graft healing for cancellous or vascularized bone grafts. Because these grafts are revascularized rapidly, osteoblasts survive the transplantation and produce new bone at the recipient site.
Osteoinduction
Osteoinduction involves the stimulation of mesenchymal cells at the recipient site to differentiate into bone-producing cells. Demineralized bone and bone morphogenetic protein produce new bone primarily by osteoinduction.
Vasculogenesis
Vasculogenesis, the de novo formation of blood vessels from precursor cells, occurs during embryogenesis.
Angiogenesis
Angiogenesis: the production of new vessels from preexisting vasculature.
A 24-year-old woman comes to the office because of painful nodules in both buttocks. She underwent buttock augmentation with injections of liquid silicone by an unlicensed practitioner 4 years ago. Excision of the affected area is performed. Histology of a specimen obtained from the excised tissue is most likely to show which of the following? A) Acellularity B) Calcification C) Granuloma D) Necrosis E) Thrombosis
C) Granuloma
Potential adverse sequelae after silicone injection
Potential adverse sequelae following silicone injection include migration, chronic induration and pigmentary changes, painful subcutaneous nodules, chronic infection, and ulceration. Many of the treated areas require radical resection and reconstruction.
Histologic study of postsilicone injection nodules
Histologic study of postsilicone injection nodules typically shows granulomas which develop after initial inflammation and fibrosis.
A 15-year-old boy undergoes negative pressure wound therapy (NPWT) of a traumatic abdominal wound. Which of the following is the most likely mechanism by which NPWT expedites the healing of this wound?
A) Decrease in bacterial burden
B) Deformation of the wound
C) Desiccation of the wound
D) Increase in matrix metalloproteinase activity
E) Maintenance of exudate from the wound
B) Deformation of the wound
NPWT Macrodeformation
Macrodeformation maintains approximation of the tissues, preventing loss of domain and facilitating earlier closure by delayed primary or secondary intention.
NPWT Microdeformation
Microdeformation at the interface of the sponge and wound bed changes cell shape, which then affects gene transcription via the cytoskeleton (mechanotransduction). These microdeformational forces, for example, stimulate cellular proliferation and angiogenesis in the wound.
NPWT and bacterial burden
The effect of NPWT on bacterial burden is unclear. Some studies have suggested that NPWT reduces bacterial counts in the wound, possibly by direct removal or by increasing blood flow. Other studies have found that NPWT may increase certain bacterial levels.
NPWT and desiccation
NPWT prevents desiccation of the wound. The semiocclusive polyurethane drape limits permeability to gases and water vapor and thus maintains a favorable, moist wound environment.
NPWT and matrix metalloproteinase activity
NPWT decreases matrix metalloproteinase activity in the wound. Elevated matrix metalloproteinases inhibit wound healing as well as neovascularization.
NPWT and exudate
NPWT decreases exudate of the wound by removing excess fluid through suction. The reduction in exudate may facilitate wound healing by removing toxic inflammatory mediators and proteinases. Minimizing wound edema also may improve the diffusion of oxygen and nutrients to the wound.
A 63-year-old man comes for evaluation of a dehisced surgical incision 3 weeks after undergoing open reduction of the right ankle. He has a history of coronary artery disease, hypertension, hypercholesterolemia, and poorly controlled type 2 diabetes mellitus. He had a myocardial infarction 2 years ago. Physical examination shows a dehisced surgical incision with exposed tibialis anterior tendon without paratenon. A photograph is shown. The patient refuses free tissue transfer. Which of the following is the most appropriate skin substitute for the wound?
A) Biodegradable bilaminate neodermal matrix (Integra)
B) Biosynthetic wound dressing (Biobrane)
C) Cryopreserved neonatal fibroblast-derived dermal substitute (Dermagraft)
D) Human fibroblast-derived composite skin substitute (TransCyte)
E) Living bilayered skin substitute (Apligraf)
A) Biodegradable bilaminate neodermal matrix (Integra)
Integra
Integra is a bilaminate neodermal replacement product that is composed of a biodegradable bovine collagen-glycosaminoglycan (collagen-GAG) matrix underlayer with a silicone outer layer. Although its on-label indication is for burn reconstruction, it also has utility in reconstruction of wounds of exposed bone without periosteum, exposed cartilage without perichondrium, and exposed tendon without paratenon, such as in the scenario described. The collagen-GAG matrix serves as scaffolding for the ingrowth of cells and neovascularization. After regeneration, which takes between 2 to 4 weeks, the silicone outer later is removed and a thin split-thickness skin graft completes the reconstruction by providing epithelial cells over the neovascularized dermal replacement.
Biobrane
Biobrane is a temporary, rather than permanent, bilaminar skin substitute that is constructed of an inner layer, composed of nylon and collagen, which is covered by an outer silicone film. Biobrane serves as a temporary wound dressing, usually in burn patients, where it helps prevent evaporative loss (due to the silicone outer layer) and subsequent wound desiccation. It decreases wound pain and provides a barrier to bacterial infection. Biobrane is removed either before permanent grafting or after epithelialization of the wound has occurred.
Dermagraft
Dermagraft is a dermal substitute composed of neonatal foreskin fibroblasts cultured on a polyglactin mesh, and it is generally used in the treatment of diabetic foot ulcers, where it often is combined with meshed skin grafts